GEO Partner (Switzerland)

Evaluating plasma renin activity as a monitoring parameter for mineralocorticoid treatment in dogs with primary hypoadrenocorticism

Abstract Background In human medicine, plasma renin activity (PRA) is used to assess mineralocorticoid treatment adequacy in hypoadrenocorticism, with elevated levels indicating under-replacement and suppressed levels over-replacement. In dogs with primary hypoadrenocorticism, PR...